bioAffinity Technologies Files For U.S. IPO (Pending:BIAF)
BioAffinity Technologies has filed to raise capital via a U.S. IPO. The firm is developing a lung cancer detection test. Read what to know about the IPO here.
Source: seekingalpha.com
Stay updated with breaking news from Cypath Lung. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BioAffinity Technologies has filed to raise capital via a U.S. IPO. The firm is developing a lung cancer detection test. Read what to know about the IPO here.